Ayutara ...
Clinical Advisory Board

Evidence-Led Guidance for Safer, Faster Clinical Impact

Physician-scientists advising trial design, endpoints, biomarker strategy and theranostic workflows—bringing precision and practicality to every study.

Meet the Advisors Focus Areas
Clinical-Grade
✓ Multi-Center Ready
✓ Theranostic Experts
✓ RWE + PROs
✓ Patient-First

Who We Are

A global group of oncologists, nuclear-medicine specialists and translational scientists providing scientific rigor, regulatory foresight and operational realism across programs.

From first-in-human to pivotal trials, we ensure endpoints, selection and workflows align with clinical practice and patient needs.

Endpoints that matter
PFS, ORR, PET response, PROs & HRQoL.
Theranostic pathways
PSMA/SSTR imaging-therapy integration.
Sequencing frameworks
RLT with SOC/IO/chemo for durability.
Access & enablement
Site readiness and safe scale-up.

Strategic Focus Areas

Where our CAB shapes high-impact decisions to maximize outcomes and feasibility.

T1
Trial Architecture

Adaptive Phase I–III designs, cohort strategy and stats aligned to standards of care.

BM
Biomarkers & CDx

Eligibility thresholds, imaging positivity, and companion diagnostic readiness.

TH
Theranostic Integration

PSMA/SSTR workflows for selection, dosing and response assessment.

SQ
Sequencing

Optimal order with SOC/IO/chemo to improve durability while limiting toxicity.

EP
Endpoints & PROs

PFS, ORR, PET response plus HRQoL for meaningful clinical evidence.

AX
Access & Pathways

Site enablement, safety frameworks and RWE programs for scale.

Advisory Panel

Global physician-scientists translating innovation into clinical practice.

Dr. Jonathan Miles
Medical Oncology — Prostate

PSMA-focused designs, biomarker selection and sequencing.

Dr. Aisha Raman
Nuclear Medicine — Theranostics

Standardized imaging-therapy workflows and response frameworks.

Dr. Emma Chen
Translational Science

Biologic rationale for combinations and adaptive designs.

Collaboration Framework

A clear path from concept to clinical impact.

01
Program Review

Target rationale, unmet need and feasibility mapping.

02
Trial Architecture

Design, endpoints, eligibility and imaging schemas.

03
Clinical Enablement

Sites, pathways, safety and data capture plans.

04
Evidence & Access

PROs, RWE, publications and scale-ready delivery.

Work With Our Clinical Advisory Board

Let’s co-design pragmatic, high-impact studies and enable safe access for patients.

Start a Conversation